| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/30/2009 | WO2008144611A3 Il-9 in fibrotic and inflammatory disease |
| 12/30/2009 | WO2008137699A3 Topical formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice with multiple modes of action |
| 12/30/2009 | WO2008118487A3 Compositions and methods for incresing immunogenicity of glycoprotein vaccines |
| 12/30/2009 | WO2008112344A3 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins |
| 12/30/2009 | EP2138582A2 DNA and specific peptides or proteins of bacteria of the species neisseria meningitidis, methods for obtaining same and their biological applications |
| 12/30/2009 | EP2138576A1 Anti-claudin-4 antibody |
| 12/30/2009 | EP2138509A1 Tumor-associated peptide binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 12/30/2009 | EP2138187A1 Probiotics, secretory IgA and infection |
| 12/30/2009 | EP2138186A1 Probiotics, secretory IgA and inflammation |
| 12/30/2009 | EP2138179A1 Use of cytidine derivatives for the treatment of leukaemia |
| 12/30/2009 | EP2137216A2 Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer |
| 12/30/2009 | EP2137215A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 12/30/2009 | EP2137214A1 Novel human anti-r7v antibodies and uses thereof |
| 12/30/2009 | EP2136840A2 Use of an anti-cxcr4 antibody for treating cancer |
| 12/30/2009 | EP2136839A2 Stable antibody formulations |
| 12/30/2009 | EP2136838A2 Epha3 antibodies for the treatment of solid tumors |
| 12/30/2009 | EP2136837A1 Oil-in-water emulsion influenza vaccine |
| 12/30/2009 | EP2136836A2 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof |
| 12/30/2009 | EP2136835A1 Vaccine |
| 12/30/2009 | EP2136834A1 A non-destructive method to quantify and isolate antigen-specific b cells and uses thereof |
| 12/30/2009 | EP2136832A1 Methods for promoting protection and regeneration of bone marrow using cxcl9 and anti-cxcl9 antibodies |
| 12/30/2009 | EP2136820A1 A target for breast cancer therapy and/or diagnosis |
| 12/30/2009 | EP1904102B1 Anti-ccr7 receptor antibodies for the treatment of cancer |
| 12/30/2009 | EP1689432B1 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 12/30/2009 | EP1504037B1 Ferritin fusion proteins for use in vaccines and other applications |
| 12/30/2009 | EP1470239B1 Psoriasin expression by breast epithelial cells |
| 12/30/2009 | CN101616690A Methods for the treatment of il-1ss related diseases |
| 12/30/2009 | CN101616689A CCR2 antagonists for treatment of fibrosis |
| 12/30/2009 | CN101616688A Herpes simplex virus combined subunit vaccines and methods of use thereof |
| 12/30/2009 | CN101616687A Non-specific immunostimulating agents |
| 12/30/2009 | CN101616686A LIGHT-mediated anti-cell proliferative compositions and methods |
| 12/30/2009 | CN101613688A Von willebrand factor (vWF)-cleaving protease |
| 12/30/2009 | CN101613397A Neisserial antigenic peptides |
| 12/30/2009 | CN101612402A Interferon antagonist and use of Flt3L interferon |
| 12/30/2009 | CN101612399A PDGFR-alpha antagonists for treatment of metastatic bone cancer |
| 12/30/2009 | CN101612398A Inhibiting agent and accelerating agent of oxytocin |
| 12/30/2009 | CN101612397A Duck virus hepatitis inactivated vaccine and preparation method thereof |
| 12/30/2009 | CN101612396A Canine distemper live vaccine and preparation method thereof |
| 12/30/2009 | CN101612395A Method for producing blue-ear disease vaccine by culturing sensitive cell |
| 12/30/2009 | CN101612394A Streptococcus-pneumoniae-toxicity-reducing live vaccine |
| 12/30/2009 | CN100575491C Trans menbrance type and secretory type HIV Gag antigen code gene and AIDS vaccine containing said gene |
| 12/30/2009 | CN100575482C Novel cytokine zcytor17 ligand |
| 12/30/2009 | CN100575364C Antibodies for inhibiting blood coagulation and methods of use thereof |
| 12/30/2009 | CN100575363C Human source anti-A botulinum neurotoxin genetic engineering antibody and preparation method and use thereof |
| 12/30/2009 | CN100575361C Humanized single chain antibody for anti-human cytomegalovirus envelope glycoprotein |
| 12/30/2009 | CN100574803C Use of immunoregulation antibody for the treatment of neoplastic disorders |
| 12/30/2009 | CA2729248A1 Rapid responses to delayed booster immunisations |
| 12/30/2009 | CA2729105A1 Attenuated pestivirus |
| 12/30/2009 | CA2729098A1 Antagonists of activin-actriia and uses for increasing red blood cell levels |
| 12/30/2009 | CA2729054A1 Antagonists of actriib and uses for increasing red blood cell levels |
| 12/30/2009 | CA2729034A1 Use |
| 12/30/2009 | CA2729012A1 Ang-2 inhibition to treat multiple sclerosis |
| 12/30/2009 | CA2728735A1 Compositions and methods for enhanced somatostatin immunogenicity |
| 12/30/2009 | CA2728734A1 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof |
| 12/30/2009 | CA2728038A1 Novel immunoadjuvant flagellin-based compounds and use thereof |
| 12/30/2009 | CA2728004A1 Humanization of rabbit antibodies using a universal antibody framework |
| 12/30/2009 | CA2727992A1 Stable and soluble antibodies inhibiting tnfa |
| 12/30/2009 | CA2727839A1 Stable and soluble antibodies inhibiting vegf |
| 12/30/2009 | CA2727303A1 Probiotics, secretory iga and infection |
| 12/30/2009 | CA2727300A1 Probiotics, secretory iga and inflammation |
| 12/30/2009 | CA2726837A1 Lyophilization cycle robustness strategy |
| 12/30/2009 | CA2726465A1 Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof |
| 12/30/2009 | CA2723786A1 Novel saponin-containing adjuvants |
| 12/29/2009 | US7638679 Screening for agents that modulate tolerance to an immunogen; delivering a nucleic acid that directs expression of the immunogen to the liver of an animal, resulting in sustained expression of the immunogen in the liver. |
| 12/29/2009 | US7638619 Nucleotide sequences coding hepatocyte specific immunoglobulin for use in prevention and treatment of cell proliferative disorders; immunotherapy; antitumor agents |
| 12/29/2009 | US7638608 Assay for the separation and quantification of hemagglutinin antigens |
| 12/29/2009 | US7638607 Urocortin proteins and uses thereof |
| 12/29/2009 | US7638605 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 12/29/2009 | US7638604 Monoclonal antibodies against interleukin-22 |
| 12/29/2009 | US7638601 Transient receptor potential channel TRPM8 and its use |
| 12/29/2009 | US7638598 ErbB interface peptidomimetics and methods of use thereof |
| 12/29/2009 | US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 12/29/2009 | US7638499 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 12/29/2009 | US7638498 Substances for preventing and treating autoimmune diseases |
| 12/29/2009 | US7638492 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders |
| 12/29/2009 | US7638489 Modulation of angiogenesis by Bartonella henselae |
| 12/29/2009 | US7638481 With vaccinia virus complement control protein, poxvirus encoded |
| 12/29/2009 | US7638480 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 12/29/2009 | US7638335 Inhibit inflammation for long periods without accompanying serious side effects in the drug therapy to patients with inflammatory bowel syndrome |
| 12/29/2009 | US7638330 Method of promoting the differentiation of staminal cells |
| 12/29/2009 | US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/29/2009 | US7638305 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing |
| 12/29/2009 | US7638304 Hybrid fusion protein transcription regulator to induce interferon target gene expression |
| 12/29/2009 | US7638284 analysis; detect IgA deficiency in a mammal, using antibody specific for Immunoglobulin A Inducing Protein; polyclonal antibody; monoclonal antibody; immunoassay for mammalian mucosal immune system |
| 12/29/2009 | US7638282 Genes of an otitis media isolate of nontypeable Haemophilus influenzae |
| 12/29/2009 | US7638277 Diagnosing ovarian cancer by detecting a TADG-12 protein in biological sample, immunoaffinity to an antibody, bioassay, immunoassay |
| 12/29/2009 | US7638272 administering a polypeptide to the cancer cells of the mammal in vivo for sensitizing the cancer cells to the therapeutic chemotherapy, radiation treatment; gene expressed polypeptide; secreted protein acidic and rich in cystein |
| 12/29/2009 | US7638271 Use of antibody from lymphocyte secretions to diagnose active infection |
| 12/29/2009 | US7638136 fusion proteins; encode hyperimmune serum reactive antigen or fragment thereof; immunogens |
| 12/29/2009 | US7638135 Collagen-binding proteins from enterococcal bacteria |
| 12/29/2009 | US7638134 Insertion sites in fowlpox vectors |
| 12/29/2009 | US7638133 transformed with an expression vector that has a polynucleotide encoding a foreign antigenic protein, wherein the polynucleotide is a modified one in which the third position of each codon is substituted with G or C without a change of an amino acid; against human immunodeficiency virus infection |
| 12/29/2009 | US7638132 genetically stable vaccinia viruses and vaccinia virus vectors with higher safety, which undergo reversion with difficulty because of the removal of a gene involved in reversion from an attenuated smallpox vaccinia virus LC16m8 strain or its parental LC16mO strain, which tends to undergo reverse mutation |
| 12/29/2009 | US7638131 Coccidiosis poultry vaccine |
| 12/29/2009 | US7638130 Modified obligate parasite polypeptide for use in treatment and prevention of scrub typhus infection |
| 12/29/2009 | US7638127 Peptide conjugated anti-cancer prodrugs |
| 12/29/2009 | US7638126 Methods of treating pain and inflammation in neuronal tissue using antagonists of IL-31, IL31Ra and/or OSMRb |
| 12/29/2009 | US7638125 different epitopes are located within the binding domain of the natural ligand(s) of said receptor; first and second antigen-binding site binds to a different epitope on the same EGFR molecule; anticarcinogenicb antimetastasis agents |
| 12/29/2009 | US7638124 Antigen-presenting complex-binding compositions and uses thereof |
| 12/29/2009 | US7638122 Stat3 antagonists and their use as vaccines against cancer |